background
studi
sought
inhibit
herp
simplex
viru
type
replic
use
small
interf
rna
target
infectedcel
polypeptid
gene
mediat
transcript
earli
late
viral
gene
herp
simplex
viru
type
lytic
product
infect
retina
epitheli
cell
method
preor
postinfect
herp
simplex
viru
type
small
interf
rna
transfect
retina
epitheli
cell
antivir
effect
small
interf
rna
evalu
western
blot
plaqu
assay
indirect
immunofluoresc
revers
transcript
polymeras
chain
reaction
viral
titr
detect
tissu
cultur
infect
dose
method
result
small
interf
rna
decreas
infectedcel
polypeptid
express
retina
epitheli
cell
infect
herp
simplex
viru
type
small
interf
rna
transfect
compar
herp
simplex
viru
type
infect
alon
transfect
neg
control
small
interf
rna
viral
titr
retina
epitheli
cell
cytopath
effect
significantli
decreas
retina
epitheli
cell
transfect
infectedcel
polypeptid
small
interf
rna
nm
p
small
interf
rna
effect
silenc
herp
simplex
viru
type
infectedcel
polypeptid
express
mrna
protein
level
p
inhibit
infectedcel
polypeptid
small
interf
rna
infectedcel
polypeptid
protein
express
also
verifi
western
blot
herp
simplex
viru
type
infect
human
cornea
epitheli
cell
human
trabecular
meshwork
cell
vero
cell
conclus
infectedcel
polypeptid
small
interf
rna
inhibit
herp
simplex
viru
type
replic
retina
epitheli
cell
provid
foundat
develop
rna
interfer
antivir
therapi
herp
simplex
viru
type
doublestrand
dna
viru
genom
infect
major
human
popul
express
two
distinct
transcript
pattern
lytic
product
infect
latenc
infect
lytic
infect
approxim
gene
encod
within
viral
genom
classifi
immediateearli
ie
earli
b
late
g
gene
rna
polymeras
ii
immediateearli
gene
infectedcel
polypeptid
major
regulatori
gene
requir
effici
transcript
earli
late
viral
gene
make
essenti
lytic
infect
protein
synthes
immedi
infect
bind
dna
sequencespecif
manner
homodim
su
et
al
report
protein
play
import
role
mediat
circular
viral
genom
delet
mutant
fail
assum
endless
circular
conform
follow
infect
addit
previous
associ
format
viral
replic
compart
increas
format
transcript
preiniti
complex
tata
boxdepend
manner
studi
suggest
interven
earli
step
format
transcript
initi
complex
mechan
recruit
fundament
differ
activ
gene
late
gene
whose
express
depend
ie
earlyprotein
function
viral
dna
replic
activ
domain
suggest
recruit
gener
transcript
factor
coactiv
ie
promot
via
proteinprotein
interact
reduc
associ
histon
promot
thu
activ
transcript
ie
gene
result
cascad
gene
transcript
consid
essenti
replic
activ
transcript
five
ie
gene
activ
remaind
hsv
genom
function
level
transcript
initi
contribut
lytic
cascad
viral
gene
express
retin
pigment
epitheli
cell
rpe
form
outermost
layer
retina
play
vital
role
mainten
human
retina
provid
target
viral
invas
evid
shown
infect
rpe
vitro
vivo
amplicon
vector
rapidli
effici
transfer
gene
rpe
vivo
retin
especi
acut
retin
necrosi
arn
caus
infect
alway
lead
sever
complic
patient
arn
blind
diseas
mark
rapidli
progress
peripher
retin
necrosi
first
describ
second
common
caus
arn
lead
caus
arn
patient
older
year
arn
may
result
direct
invas
recurr
previou
episod
retin
kerat
andor
enceph
caus
viru
furthermor
latent
infect
occur
adult
may
trigger
event
trauma
uv
irradi
neurosurgeri
highdos
corticosteroid
therefor
suppress
product
infect
viru
vital
clinic
practic
control
diseas
rna
interfer
rnai
posttranscript
process
specif
mrna
target
degrad
mean
inhibit
synthesi
encod
protein
rnai
technolog
report
ideal
tool
treatment
infecti
diseas
silenc
viral
gene
inhibit
replic
rnai
also
report
inhibit
replic
use
small
interf
rna
sirna
target
glycoprotein
e
report
mrna
target
express
also
inhibit
lat
studi
sirna
use
inhibit
replic
rpe
silenc
viral
gene
show
sirna
significantli
decreas
express
inhibit
viral
replic
rpe
addit
found
sirna
still
inhibit
viral
replic
postinfect
mimic
clinic
treatment
lytic
infect
moreov
also
downregul
protein
express
human
corneal
epitheli
cell
hce
human
trabecular
meshwork
cell
htm
vero
cell
support
inhibit
replic
vitro
retin
pigment
epithelium
cell
line
cultur
supplement
newborn
bovin
serum
gibco
grand
island
ny
usa
air
incub
stock
f
strain
propag
cell
grown
newborn
bovin
serum
african
green
monkey
kidney
cell
vero
cell
grown
supplement
newborn
bovin
serum
hce
cell
line
cultur
dmemhigh
glucos
supplement
foetal
bovin
serum
gibco
ngml
human
epiderm
growth
factor
egf
sigma
st
loui
mo
usa
mgml
human
transferrin
sigma
mgml
insulin
mgml
hydrocortison
gibco
brl
htm
cell
line
cultur
contain
foetal
bovin
serum
cell
infect
use
previous
describ
method
viral
titr
determin
accord
previous
describ
method
briefli
cell
infect
harvest
indic
time
frozen
thaw
repeatedli
centrifug
rpm
min
remov
cellular
debri
supernat
aliquot
serial
dilut
use
infect
vero
cell
triplic
three
sirna
neg
control
sirna
mock
chemic
synthes
guangzhou
ribobio
co
ltd
guangzhou
china
mock
target
known
gene
sirna
pool
reconstitut
rehydr
enzymefre
water
ribobio
guangzhou
china
divid
final
concentr
mm
per
tube
store
use
rpe
transfect
nm
sirna
mock
follow
infect
moi
h
posttransfect
use
western
blot
analysi
found
one
among
three
sirna
reveal
effect
inhibit
express
two
data
shown
use
subsequ
experi
sequenc
sirna
duplex
gcaacagcagcuccuu
caudtdt
dtdtcguugucgucgagga
agua
target
sequenc
sirna
sirna
transfect
perform
preor
postvir
infect
experi
cell
would
pretreat
sirna
rpe
grown
confluenc
transfect
specif
nm
sirna
mock
sirna
mock
without
sirna
sirna
lipofectamin
accord
manufactur
instruct
invitrogen
carlsbad
ca
usa
cell
incub
transfect
mixtur
h
cultur
newborn
bovin
serum
h
cell
infect
moi
h
gentl
shake
everi
min
allow
viral
absorpt
cell
cultur
serumfre
experi
cell
would
treat
sirna
follow
viru
infect
rpe
grown
confluenc
cell
infect
moi
follow
transfect
sirna
h
pi
use
western
blot
analysi
found
dramat
inhibit
occur
cell
transfect
sirna
h
pi
data
shown
transfect
h
pi
appli
conduct
present
studi
indic
time
cell
harvest
analys
plaqu
assay
conduct
describ
previou
literatur
experi
cell
would
pretreat
sirna
rpe
grown
plate
confluenc
transfect
sirna
mock
sirna
lipofectin
h
posttransfect
cell
infect
moi
h
cell
overlaid
ml
mixtur
low
meltingtemperatur
agaros
nusiev
gtg
agaros
cambrex
bio
sci
inc
charl
citi
ia
usa
experi
cell
would
treat
sirna
follow
viru
infect
rpe
grown
confluenc
follow
infect
moi
h
transfect
sirna
h
posttransfect
cell
overlaid
mixtur
lowmeltingtemperatur
agaros
incub
h
agaros
remov
plate
stain
crystal
violet
min
photograph
plaqu
size
measur
photoshop
softwar
calcul
imagej
softwar
http
rsbwebnihgovijindex
html
experi
repeat
least
three
time
rpe
grown
glass
coverslip
chamber
dish
use
indirect
immunofluoresc
analysi
accord
method
describ
previous
slidemount
cell
infect
transfect
sirna
describ
earlier
indic
time
slide
incub
mous
antihuman
monoclon
antibodi
recogn
immedi
earli
protein
abcam
cambridg
uk
overnight
rins
sever
time
phosphatebuff
salin
pb
cell
incub
fitcconjug
secondari
goat
antimous
igg
antibodi
zhongshan
goldenbridg
beij
china
h
slide
rins
pb
nuclei
stain
propidium
iodid
seal
antifad
solut
applygen
beij
china
cell
observ
use
confoc
laser
scan
microscop
carl
zeiss
jena
germani
addit
cell
incub
pb
instead
first
antibodi
use
neg
control
experi
repeat
triplic
cell
sampl
frozen
thaw
three
time
centrifug
rpm
min
remov
cellular
debri
protein
content
supernat
determin
bicinchonin
acid
method
use
bsa
standard
western
blot
conduct
accord
establish
method
briefli
cell
lysat
boil
sampl
buffer
min
protein
load
lane
sodium
dodecylsulfatepolyacrylamid
gel
transfer
onto
polyvinyliden
difluorid
membran
electrophoresi
block
tbst
fatfre
dri
milk
tween
mm
nacl
mm
tri
ph
h
membran
expos
mgml
mous
sirna
inhibit
herp
simplex
viru
type
antibodi
abcam
mgml
mous
antigapdh
kangchen
shanghai
china
separ
incub
overnight
incub
secondari
goat
antimous
igg
antibodi
zhongshan
goldenbridg
beij
china
h
protein
band
visual
use
kit
chemiluminesc
phototop
r
hrp
western
blot
detect
system
cell
signal
technolog
inc
danver
usa
expos
kodak
imag
station
kodak
rochest
ny
usa
averag
data
obtain
least
three
independ
experi
cellular
total
rna
isol
trizol
reagent
invitrogen
accord
manufactur
instruct
subsequ
rna
reversetranscrib
cdna
revertaid
first
strand
cdna
synthesi
kit
fermenta
glen
burni
md
usa
cdna
amplifi
kit
gotaq
green
master
mix
promega
madison
wi
usa
primer
forward
revers
bp
wherea
gapdh
primer
forward
revers
bp
pcr
condit
min
cycl
min
pcr
band
agaros
gel
analyz
kodak
molecular
imag
softwar
experi
repeat
least
three
time
get
averag
data
rel
rna
level
normal
gapdh
rna
level
experi
conduct
minimum
three
time
similar
result
quantit
data
express
mean
standard
deviat
compar
differ
viral
titr
express
mrna
rtpcr
protein
western
blot
among
differ
treat
cell
statist
analysi
data
perform
oneway
anova
spss
spss
cari
nc
usa
p
consid
statist
signific
rpe
transfect
sirna
nm
preor
infect
multipl
infect
moi
inhibitori
effect
sirna
shown
figur
first
transfect
sirna
administ
h
prior
infect
h
postinfect
pi
sirna
inhibit
express
protein
wherea
effect
express
mock
sirna
fig
plaqu
test
demonstr
treat
sirna
result
format
larger
number
plaqu
result
similar
mock
sirna
howev
treatment
significantli
decreas
plaqu
size
number
fig
e
p
second
infect
rpe
h
transfect
nm
result
show
sirna
also
inhibit
express
compar
mock
sirna
treat
sirna
fig
express
control
cell
infect
plaqu
assay
also
show
sirna
dramat
decreas
number
size
plaqu
fig
f
p
similar
transfect
prior
infect
rpe
infect
moi
h
follow
transfect
sirna
cell
h
pi
viral
titr
cell
transfect
much
lower
mock
sirna
cell
treat
sirna
fig
p
h
pi
viral
titr
greatli
increas
compar
h
pi
howev
pattern
viru
titr
among
differ
treat
cell
inconsist
h
pi
gener
reduc
viral
replic
h
pi
h
pi
compar
propag
mock
sirnatr
cell
fig
p
howev
although
viru
titr
tend
lower
express
nm
sirnatr
cell
nm
sirnatr
cell
statist
analysi
show
signific
differ
p
infect
moi
h
rpe
transfect
cell
morpholog
chang
observ
phasecontrast
microscop
fig
follow
infect
h
pi
obviou
differ
cellular
morpholog
among
cell
transfect
nm
mock
sirna
without
sirna
nm
uninfect
rpe
h
pi
cytopath
effect
cpe
could
observ
mock
sirna
sirnauntr
control
cell
cell
transfect
infect
cell
usual
display
cluster
mani
individu
cell
remain
uninfect
h
pi
cpe
increas
dramat
mani
giant
multinucl
cell
could
seen
mock
sirna
sirnauntr
cell
howev
fewer
cpe
includ
giant
multinucl
cell
could
seen
cell
transfect
nm
sirna
even
fewer
cell
transfect
nm
sirna
first
protein
express
observ
indirect
immunofluoresc
infect
cell
compar
cell
transfect
mock
sirna
without
sirna
intens
immunostain
dramat
decreas
rpe
transfect
h
pi
fig
higher
magnif
microscop
found
protein
mainli
local
rpe
nuclei
took
part
transcript
activ
clearli
less
stain
nm
sirna
transfect
cell
nm
sirna
transfect
cell
effect
sirna
target
protein
also
detect
western
blot
use
antibodi
fig
h
pi
express
decreas
lysat
rpe
transfect
sirna
untreat
cell
p
similarli
inhibit
express
cell
transfect
mock
sirna
although
protein
tend
lower
express
nm
sirnatr
cell
compar
nm
sirna
statist
analysi
show
signific
differ
p
fig
transcript
activ
lytic
infect
involv
activ
immedi
earli
gene
includ
order
valid
interf
effect
sirna
viral
replic
determin
rtpcr
fig
rpe
infect
moi
h
pi
sirna
transfect
cultur
h
pi
express
decreas
cell
transfect
sirna
compar
sirna
untreat
cell
p
mock
sirna
show
effect
express
hce
htm
vero
cell
infect
moi
follow
transfect
nm
sirna
protein
express
analyz
western
blot
fig
compar
cell
transfect
mock
without
sirna
express
dramat
decreas
hce
fig
b
htm
fig
vero
cell
fig
f
transfect
h
pi
major
pathogen
human
be
caus
varieti
diseas
even
lifethreaten
earli
key
transcript
activ
replic
target
began
studi
goal
inhibit
replic
sirna
target
viral
show
sirna
significantli
suppress
express
decreas
viral
level
cultur
rpe
less
cpe
lower
viral
titr
seen
rpe
transfect
compar
cell
treat
mock
sirna
sirnauntr
control
cell
tegument
protein
gene
compon
virion
facilit
immediateearli
gene
express
cascad
gene
transcript
decreas
rpe
treat
sirna
mainli
sirna
decreas
replic
furthermor
downregul
express
demonstr
hce
htm
vero
cell
fig
result
suggest
use
sirna
potent
inhibit
replic
may
potenti
clinic
applic
crucial
role
lytic
infect
major
transcript
activ
requir
activ
express
gene
function
mediat
circular
genom
constitut
viral
replic
compart
format
microfoci
product
infect
demonstr
literatur
also
involv
deloc
nucleolin
abund
host
nucleoli
protein
nucleu
cytoplasm
form
aggresom
degrad
addit
express
regul
repressor
element
silenc
transcript
factorneuron
restrict
silenc
factor
restnrsf
may
play
import
role
establish
andor
mainten
gene
silenc
latent
infect
rnai
technolog
use
silenc
gene
express
directli
target
specif
sequenc
mrna
report
ideal
tool
treatment
viral
infecti
diseas
silenc
viral
gene
mani
public
describ
inhibit
virus
includ
human
immunodefici
viru
type
heper
simplex
viru
hsv
hepat
b
viru
hbv
hepat
c
viru
hcv
target
silenc
divers
viral
gene
well
cell
gene
essenti
viru
replic
studi
appli
rnai
interfer
infect
zhe
et
al
exampl
report
synthet
sirna
silenc
specif
gene
code
inhibit
replic
vero
cell
also
evid
sirna
specif
glycoprotein
e
suppress
glycoprotein
e
express
reproduc
gedelet
mutant
viru
keratinocyt
addit
use
rnai
cellular
dna
ligas
iii
iv
muylaert
colleagu
found
dna
ligas
iv
cofactor
reduc
product
human
fibroblast
hand
rnaimedi
deplet
neither
dna
ligas
dna
ligas
iii
appear
affect
viru
replic
rpe
target
cell
retina
use
rnai
inhibit
lytic
infect
cultur
rpe
result
show
use
dramat
reduc
replic
rpe
infect
virus
either
transfect
sirna
previou
studi
cell
transfect
sirna
infect
viru
vivo
circumst
howev
infect
host
medic
treatment
appli
need
find
way
treat
condit
viral
infect
report
gene
found
rpe
h
pi
current
studi
show
transfect
chemic
synthes
sirna
could
inhibit
protein
express
preand
rpe
fig
addit
inhibitori
effect
relat
concentr
sirna
nm
sirna
somewhat
effect
nm
fig
inhibitori
effect
sirna
concentr
depend
report
viru
infect
sar
coronaviru
hcv
hiv
studi
howev
neither
nm
sirna
nm
sirna
could
block
viral
product
suggest
sirnadeliveri
approach
need
improv
cultur
situat
vitro
perhap
prolong
period
sirna
deliveri
increas
amount
valid
sirna
cell
suppress
viru
product
effect
moreov
design
three
sirna
found
two
sirna
success
agent
although
one
effici
data
shown
sever
studi
shown
clearanc
viru
cell
cultur
occur
viru
sequenc
ident
sirna
multipl
sirna
target
one
specif
region
rna
sequenc
may
limit
emerg
escap
mutant
increas
virusinhibit
capac
therefor
use
multipl
sirna
target
gene
may
inhibit
viru
product
effect
addit
liu
et
al
report
chines
lentivir
plasmid
plkopuro
r
target
attenu
replic
vero
cell
consist
result
suggest
suppress
effect
inhibit
product
howev
consid
applic
rnai
vivo
chemic
synthes
sirna
effici
deliv
cell
less
side
effect
use
direct
introduct
synthet
sirna
impend
therapeut
applic
base
rnai
propos
recent
deliv
gene
sirna
intravitr
subretin
inject
report
treatment
retin
diseas
exampl
sirna
antivascular
endotheli
growth
factor
vegf
use
patient
neovascular
result
agerel
macular
degener
stabil
improv
visual
acuiti
observ
furthermor
studi
report
subretin
inject
adenoassoci
viral
vector
encod
safe
case
effect
patient
leber
congenit
amaurosi
addit
use
intravitr
administr
sirna
underw
clinic
trial
differ
compani
major
pathogen
ophthalm
infect
caus
varieti
ocular
diseas
rang
mild
sever
even
result
blind
reveal
vitro
could
suppress
reproduct
rpe
might
effect
way
inhibit
replic
retina
use
intravitr
inject
summari
demonstr
synthes
sirna
exhibit
excel
antivir
activ
inhibit
replic
rpe
find
provid
foundat
studi
use
sirna
effect
antivir
agent
infect
vivo
studi
elucid
uniqu
insight
may
provid
therapi
control
retin
infect
